{'fraction_non_alphanumeric': 0.04291044776119403, 'fraction_numerical': 0.03731343283582089, 'mean_word_length': 5.244186046511628, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Priorities for control of malignant melanoma in Europe.

Cutaneous malignant melanoma (CMM) accounts for the large majority of deaths from skin cancer in young and middle-aged adults. CMM is strongly associated with intense and intermittent sun exposure, particularly early in life (IARC, 1992; Armstrong and Kricker, 1993; Elwood and Jopson, 1997; English et al., 1997). It is consequently a potentially preventable neoplasm. CMM is also effectively treated, provided that early diagnosis of thin lesions is available (Austoker, 1994).